Advanced Search

Technical Analysis for ESPR - Esperion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 30.76 -6.70% -2.21
ESPR closed down 6.7 percent on Friday, April 3, 2020, on 69 percent of normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ESPR trend table...
Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Bullish Engulfing Bullish -6.70%
Multiple of Ten Bullish Other -6.70%
Outside Day Range Expansion -6.70%
Wide Bands Range Expansion -6.70%
NR7 Range Contraction 2.40%
Multiple of Ten Bullish Other 2.40%
Wide Bands Range Expansion 2.40%
Older EOD signals for ESPR ...
View Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
ESPR Chart by TradingView
Basic chart:

Profile

Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Its products include ETC-1002, an oral molecule therapy that is in Phase IIa clinical trials to treat lipid and carbohydrate metabolic pathways; ESP41091, which is in pre-clinical trials for type 2 diabetes and obesity treatment; and 4WF, a synthetic therapy that is in pre-clinical trials to reverse the deleterious effects of atherosclerosis. The company is based in Plymouth, Michigan.
Biopharmaceutical Medical Specialties Diabetes Obesity Cardiology Cholesterol Gabaa Receptor Positive Allosteric Modulators Lipids Low Density Lipoprotein Lipoproteins Atherosclerosis

Is ESPR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Apr 1 Oppenheimer sees 26% downside in Intuitive Surgical in premarket action
Mar 30 Esperion launches cholesterol med bempedoic acid in U.S.
Mar 30 Esperion Announces Commercial Availability of the NEXLETOL™ (bempedoic acid) Tablet and Pledges a Conscientious Launch During Unprecedented Moment in Healthcare
Mar 28 Esperion Therapeutics (ESPR) Down 32.5% Since Last Earnings Report: Can It Rebound?
Mar 28 Esperion Announces Three Data Presentations of the NEXLETOL™ (bempedoic acid) Tablet and the NEXLIZET™ (bempedoic acid and ezetimibe) Tablet at the American College of Cardiology’s 69th Annual Scientific Session Together with World Congress of Cardiolo...
Mar 23 Esperion Announces Pooled Analyses from Phase 3 LDL-C Lowering Development Program of the NEXLETOL™ (bempedoic acid) Tablet and Phase 2 Study Results of the NEXLIZET™ (bempedoic acid and ezetimibe) Tablet to be Presented at the American College of Card...
Mar 18 Esperion Announces the Appointment of Alan Fuhrman to its Board of Directors
Mar 17 BMO likes Blueprint Medicines in premarket analyst action
Feb 29 The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off
Feb 28 Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
See more ESPR news...

Indicators

Indicator Value
52 Week High 76.98
52 Week Low 24.82
Average Volume 984,678
200-Day Moving Average 45.61
50-Day Moving Average 49.83
20-Day Moving Average 35.49
10-Day Moving Average 34.27
Average True Range 4.39
ADX 33.92
+DI 17.84
-DI 32.32
Chandelier Exit (Long, 3 ATRs ) 42.94
Chandelier Exit (Short, 3 ATRs ) 37.98
Upper Bollinger Band 45.01
Lower Bollinger Band 25.97
Percent B (%b) 0.25
BandWidth 53.65
MACD Line -5.20
MACD Signal Line -5.49
MACD Histogram 0.2898
Fundamentals Value
Market Cap 696.28 Million
Num Shares 22.6 Million
EPS -5.77
Price-to-Earnings (P/E) Ratio -5.33
Price-to-Sales 0.00
Price-to-Book 6.37
PEG Ratio -4.32
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.60
Resistance 3 (R3) 36.96 35.37 35.62
Resistance 2 (R2) 35.37 33.89 35.19 35.30
Resistance 1 (R1) 33.07 32.97 32.28 32.71 34.97
Pivot Point 31.48 31.48 31.09 31.30 31.48
Support 1 (S1) 29.18 30.00 28.39 28.82 26.55
Support 2 (S2) 27.59 29.08 27.41 26.22
Support 3 (S3) 25.29 27.59 25.90
Support 4 (S4) 24.93